The Observation Of Safety And Survival Of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Combined With Anti-hepatitis B Virus Therapy (TACEHBV)

NCT01102335 Phase 4 UNKNOWN

The purpose of this study is to elucidate the influence of anti-hepatitis B virus therapy on safety and survival of HCC patient after transcatheter arterial chemoembolization.

Details

Lead sponsor	Fudan University
Phase	Phase 4
Status	UNKNOWN
Enrolment	80
Start date	2010-04
Completion	2012-12

Conditions

• Hepatocellular Carcinoma

Interventions

• Transcatheter arterial chemoembolization (TACE)
• Telbivudine

Primary outcomes

• Number of Participants with Adverse Events as a Measure of Safety and Tolerability — 6 months

Countries

China